chr8-139731216-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001160372.4(TRAPPC9):āc.3292G>Cā(p.Gly1098Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,418 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1098S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001160372.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRAPPC9 | NM_001160372.4 | c.3292G>C | p.Gly1098Arg | missense_variant | 23/23 | ENST00000438773.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRAPPC9 | ENST00000438773.4 | c.3292G>C | p.Gly1098Arg | missense_variant | 23/23 | 1 | NM_001160372.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000128 AC: 32AN: 249338Hom.: 0 AF XY: 0.000163 AC XY: 22AN XY: 135188
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1461106Hom.: 3 Cov.: 32 AF XY: 0.0000770 AC XY: 56AN XY: 726864
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152312Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 11, 2014 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.3586G>C (p.G1196R) alteration is located in exon 23 (coding exon 23) of the TRAPPC9 gene. This alteration results from a G to C substitution at nucleotide position 3586, causing the glycine (G) at amino acid position 1196 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Intellectual disability, autosomal recessive 13 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The observed missense variant c.3292G>C(p.Gly1098Arg) in TRAPPC9 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.3292G>C variant is reported with 0.01% allele frequency in gnomAD Exomes. It has been submitted to ClinVar as Uncertain Significance. However, study on multiple affected individuals and functional impact of the variant is not available. The amino acid Glycine at position 1098 is changed to a Arginine changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Gly1098Arg in TRAPPC9 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at